Fundraising Fox
Ona Therapeutics
Founded 2019 · 41 employees on LinkedIn · 9 known investors
Find your way into Ona Therapeutics
Sign up to see every warm intro you have to Ona Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ona Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma. The company is a Spanish biotech firm focused on oncology with support from European and Spanish government research funding programs.
Investors · 9
How we know: Asabys Partners's portfolio page · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Fund+'s portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: Ysios Capital's portfolio page · a partner's Signal profile · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$86.6M disclosed across 1 round · 2026
- $86.6MSeries BJun 2026 · 4 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Ona Therapeutics do?
- Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma. The company is a Spanish biotech firm focused on oncology with support from European and Spanish government research funding programs.
- Who are Ona Therapeutics's investors?
- Ona Therapeutics's investors include Asabys Partners, Fund+, Korys, Mérieux Equity Partners, Ysios Capital, Alta Life Sciences, Bpifrance, CDTI and 1 more.
- How much funding has Ona Therapeutics raised?
- Ona Therapeutics has disclosed $86.6M raised across 1 round.